Rocket Lab and other space stocks no longer trade as SpaceX proxies, so the case now rests on each company's own fundamentals and catalysts. SpaceX's listing pulled money out of proxy stocks into SpaceX itself, a crowding-out that was underestimated. Rocket Lab still stands out: Nasdaq-100 inclusion brings passive inflows, Electron is reliable with a strong backlog, and Neutron's first flight is the key catalyst. Risks are a rich valuation, Neutron delays and SpaceX's falling launch costs. x.com x.comÂ




